InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by HILL MATTHEW C, Chief Financial Officer. Insider active across 1 company, notably PDS Biotechnology Corp. Cumulatively, 2 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €40k. History available since 13 December 2021. The latest transaction was filed on 13 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
2,500 shares@ US$9.000.047% mcap50.0% of flowCommon StockSEC:0001140361-21-041473:0
Ideal exit: 9 Sept 2022 (T+270)
2,500 shares@ US$9.00100.0% of flowCommon StockSEC:0001140361-21-041473
Ideal exit: 9 Sept 2022 (T+270)
2 of 2 declarations
About HILL MATTHEW C
Matthew C. Hill is the Chief Financial Officer at PDS Biotechnology Corp. He oversees financial management and budgeting strategies for the company. His expertise is essential for ensuring the financial health and compliance of the firm.
